ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, L.-T.
Right arrow Articles by Wu, L.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, L.-T.
Right arrow Articles by Wu, L.-H.

Ann Thorac Surg 1982;33:605-608
© 1982 The Society of Thoracic Surgeons

Articles

Bronchogenic Carcinoma: A Study of Patients Treated at Capital Hospital, Peking, China

Le-Tian Xu, M.D.*, Cheng-Fu Sun, M.D., Ze-Jian Li, M.D., Liang-Hong Wu, M.D.

From the Department of Surgery, Capital Hospital, Chinese Academy of Medical Sciences, Peking, China

Accepted for publication September 24, 1981.

* Address reprint requests to Dr. Xu, Vice-head and Associate Professor, Department of Surgery, Capital Hospital, Peking, China

From 1961 to 1972, 123 patients with lung cancer underwent operations at Capital Hospital, Peking, China. Ninety-six patients had resectable lesions and 27 did not, a resectability rate of 78%. Four patients (4.2%) died immediately postoperatively. Complications occurred in 8 (8.3%) patients.

Five-year survival in this group of 92 survivors was 26 (28.3%). Ten-year survival among 49 patients was 10 (20.4%). Among the 92 five-year survivors, 41.2% had squamous cell carcinoma, 25% had adenocarcinoma, and 16% had undifferentiated carcinoma. Patients with squamous cell carcinoma had a much longer survival than the others.

Six factors appear to influence survival after resection: cell type, presence of lymph node metastases, presence of tumor emboli in blood vessels, sex, age, and location. Men about 50 years of age, with a peripherally located squamous cell tumor and with no tumor emboli or lymph node metastases, have a good chance of surviving a pulmonary resection for ten years.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
B. A. Keagy, M. E. Lores, P. J. K. Starek, G. F. Murray, C. L. Lucas, and B. R. Wilcox
Elective Pulmonary Lobectomy: Factors Associated with Morbidity and Operative Mortality
Ann. Thorac. Surg., October 1, 1985; 40(4): 349 - 352.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The Society of Thoracic Surgeons.